Jianfeng Han

This publication record appears to combine work from multiple distinct researchers sharing the same name, spanning stroke treatment and clinical trials, cancer cell biology, immunology, optical communications engineering, and materials science. The stroke-related work focuses on clinical trials for acute ischemic stroke treatment, including endovascular thrombectomy and clot-dissolving drug therapies. Prospective students should verify which specific research group and institution they would be joining, as the topics listed do not form a single coherent research program.

Publication counts have fluctuated over the past decade (dropping from 10 in 2017 to as low as 3 in 2021, then rising to 18 in 2023), with no clear steady growth pattern, though recent years (2022-2025) show higher output than the mid-decade low point.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026